S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.10
+360.20
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
18.50
+1.82
+10.91%
ARCT · Arcturus Therapeutics Holdings Inc.
NASDAQ NMS - GLOBAL MARKET - Real Time Price • USD
Arcturus Therapeutics Holdings Inc (ARCT)
NASDAQ NMS - GLOBAL MARKET
Biotechnology
$11.08
+0.09
(+0.82%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$11.08
$11.05
$11.29
52-WEEK RANGE
$11.08
$5.50
$24.17
What's happening
- ARCT is up 0.82% today, trading at $11.08. — Live quote
- Volume today (20,253) is well below its 3-month average of 829,180. (Finnhub fundamentals)
- Reports earnings on 2026-11-11, 20 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.84 actual vs. $-1.02 estimated (+17.5%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 6
Buy 10
Hold 3
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (19 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
ARCT
+80.59%
vs S&P 500
+67.22%
1-YEAR RETURN
ARCT
-52.20%
vs S&P 500
-67.37%
6-MONTH RETURN
ARCT
+25.08%
3-MONTH RETURN
ARCT
+86.68%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.84
Est. $-1.02
BEAT +17.5%
2026-04-26 (Q1 2026)
$-0.95
Est. $-1.11
BEAT +14.4%
2026-01-26 (Q4 2025)
$-1.03
Est. $-0.73
MISS -41.6%
2025-10-26 (Q3 2025)
$-0.49
Est. $-0.84
BEAT +41.6%
Valuation Measures & Ratios
Enterprise Value4$123.9M
Forward P/E5—
PEG Ratio6-0.07
Price / Sales (TTM1)10.74
Price / Book71.11
EV4 / Revenue4.22
EV4 / EBITDA1.26
Profit Margin-317.62%
Operating Margin-348.33%
Return on Equity (ROE8)-46.54%
Return on Assets (ROA9)-36.46%
Avg Volume (3M)829,180
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $190.0M | $219.4M | $63.4M | $44.0M | $36.3M |
| P/E | -2.59 | -3.45 | -1.45 | -0.93 | -0.56 |
| Price/Sales | 3.76 | 2.85 | 0.54 | 0.29 | 0.23 |
| Price/Book | 1.11 | 1.15 | 0.28 | 0.19 | 0.16 |
| EV/Revenue | -0.03 | 0.10 | -1.00 | -1.02 | -1.04 |
| ROE | -42.71% | -33.27% | -19.42% | -20.50% | -27.81% |
| ROA | -32.71% | -25.94% | -15.44% | -15.32% | -19.59% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short5,378,106
Change from Prior Settlement-1.64%
% of Float—
Days to Cover (Short Ratio)5.93
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 8-K, filed 2026-09-23; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -89.5% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -317.6%. Finnhub fundamentals ↗
- Trailing 52-week price return is -52.2%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on ARCT
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.0M | $2.1M | $17.2M | $28.3M | $29.4M | $41.7M | $49.9M | $38.0M |
| Operating income | -$25.5M | -$28.9M | -$16.5M | -$11.6M | -$16.8M | -$10.7M | -$21.1M | -$30.4M |
| Net income | -$23.8M | -$27.0M | -$13.4M | -$9.2M | -$14.1M | -$6.9M | -$17.2M | -$26.8M |
| EPS (diluted) | $-0.84 | $-0.95 | $-0.49 | $-0.34 | $-0.52 | $-0.26 | $-0.64 | $-1.00 |
| EPS (basic) | $-0.84 | $-0.95 | $-0.49 | $-0.34 | $-0.52 | $-0.26 | $-0.64 | $-1.00 |
| Operating margin | -$863 | -$1.4K | -$96 | -$41 | -$57 | -$26 | -$42 | -$80 |
| Net margin | -$804 | -$1.3K | -$78 | -$32 | -$48 | -$17 | -$35 | -$71 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $224.3M | $245.4M | $271.1M | $282.3M | $309.3M | $331.8M | $344.1M | $370.7M |
| Total liabilities | $52.5M | $54.0M | $57.2M | $57.8M | $78.2M | $98.0M | $103.1M | $108.8M |
| Stockholders' equity | $171.8M | $191.4M | $214.0M | $224.6M | $231.1M | $233.8M | $241.0M | $261.9M |
| Total current assets | $197.2M | $216.9M | $241.4M | $249.2M | $274.5M | $278.8M | $306.0M | $330.8M |
| Total current liabilities | $33.5M | $34.4M | $36.4M | $31.7M | $46.5M | $49.4M | $65.5M | $69.5M |
| Cash & equivalents | $191.5M | $211.4M | $230.9M | $180.4M | $196.5M | $216.9M | $237.0M | $237.2M |
| Accounts receivable | $1.8M | $1.3M | $5.6M | $8.0M | $17.2M | $14.6M | $4.0M | $30.2M |
| Other current assets | — | — | — | — | — | — | — | — |
| Property, plant & equipment | $5.4M | $6.1M | $6.7M | $7.4M | $8.1M | $8.9M | $9.5M | $10.3M |
| Accounts payable | $4.4M | $4.1M | $4.2M | $5.5M | $10.6M | $6.2M | $7.2M | $10.1M |
| Accrued liabilities | $22.8M | $22.7M | $23.9M | $19.4M | $24.6M | $30.6M | $38.8M | $32.4M |
| Deferred revenue (current) | $6.3M | $7.6M | $8.2M | $6.8M | $11.3M | $12.7M | $19.5M | $26.9M |
| Short-term debt | — | — | — | — | — | — | — | — |
| Long-term debt | — | — | — | — | — | $15.0M | — | — |
| Other non-current liabilities | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | $28.0K | $28.0K | $28.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K |
| Retained earnings | -$565.3M | -$541.6M | -$514.6M | -$485.5M | -$472.1M | -$462.9M | -$448.8M | -$418.8M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$19.9M | -$19.4M | -$16.2M | -$17.2M | -$5.8M | -$35.1M | -$284.0K | -$23.8M |
| Investing cash flow | $18.0K | $34.0K | $88.0K | -$181.0K | $0 | -$137.0K | $0 | -$80.0K |
| Financing cash flow | $0 | $16.0K | $11.7M | $1.2M | -$14.7M | $15.2M | $134.0K | $693.0K |
| Free cash flow | -$19.9M | -$19.4M | -$16.1M | -$17.3M | -$5.8M | -$35.3M | -$284.0K | -$23.8M |
| Capital expenditures | $0 | $0 | -$88.0K | $181.0K | $0 | $137.0K | $0 | $80.0K |
| Share-based compensation | $4.2M | $4.3M | $6.8M | $5.7M | $6.2M | $6.7M | $9.0M | $9.5M |
| Change in accounts receivable | $470.0K | -$4.2M | -$2.4M | -$9.3M | $2.6M | $10.6M | -$26.2M | $6.1M |
| Change in accounts payable | $321.0K | -$142.0K | -$1.3M | -$5.0M | $4.4M | -$1.0M | -$2.9M | -$3.8M |
| Debt issued | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $82.0M | $152.3M | $166.8M | $206.0M | $12.4M |
| Operating income | -$76.3M | -$95.7M | -$78.2M | $12.2M | -$202.9M |
| Net income | -$65.8M | -$80.9M | -$29.7M | $9.3M | -$203.7M |
| EPS (diluted) | $-2.40 | $-3.00 | $-1.12 | $0.35 | $-7.74 |
| EPS (basic) | $-2.40 | $-3.00 | $-1.12 | $0.35 | $-7.74 |
| Operating margin | -$93 | -$63 | -$47 | $6 | -$1.6K |
| Net margin | -$80 | -$53 | -$18 | $5 | -$1.6K |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $271.1M | $344.1M | $429.4M | $450.4M | $392.8M |
| Total liabilities | $57.2M | $103.1M | $150.9M | $180.1M | $164.6M |
| Stockholders' equity | $214.0M | $241.0M | $278.5M | $270.3M | $228.2M |
| Total current assets | $241.4M | $306.0M | $386.6M | $403.3M | $379.0M |
| Total current liabilities | $36.4M | $65.5M | $82.0M | $127.0M | $99.5M |
| Cash & equivalents | $230.9M | $237.0M | $292.0M | $391.9M | $370.5M |
| Accounts receivable | $5.6M | $4.0M | $32.1M | $2.8M | $3.4M |
| Property, plant & equipment | $6.7M | $9.5M | $12.4M | $12.4M | $5.6M |
| Accounts payable | $4.2M | $7.2M | $5.3M | $7.4M | $10.1M |
| Accrued liabilities | $23.9M | $38.8M | $31.9M | $30.2M | $23.5M |
| Deferred revenue (current) | $8.2M | $19.5M | $44.8M | $28.6M | $43.5M |
| Short-term debt | — | — | — | $60.7M | $22.5M |
| Long-term debt | — | — | — | — | $40.6M |
| Other non-current liabilities | — | — | $497.0K | $2.8M | — |
| Common stock & paid-in capital | $28.0K | $27.0K | $27.0K | $27.0K | $26.0K |
| Retained earnings | -$514.6M | -$448.8M | -$367.9M | -$338.1M | -$347.5M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$74.3M | -$59.7M | -$18.1M | $32.0M | -$135.0M |
| Investing cash flow | -$230.0K | -$648.0K | -$2.9M | -$7.7M | -$3.4M |
| Financing cash flow | $13.4M | $5.4M | -$24.1M | -$2.9M | $48.0M |
| Free cash flow | -$74.5M | -$60.4M | -$21.0M | $24.3M | -$138.4M |
| Capital expenditures | $230.0K | $648.0K | $2.9M | $7.7M | $3.4M |
| Share-based compensation | $25.4M | $38.0M | $34.6M | $30.6M | $28.9M |
| Change in accounts receivable | $1.6M | -$28.1M | $29.3M | -$603.0K | $1.2M |
| Change in accounts payable | -$3.0M | $1.9M | -$2.2M | -$3.1M | -$769.0K |
| Debt issued | — | — | — | — | $46.6M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding ARCT as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 31 filers
Held by These Filers81.6%
Shares Outstanding28,423,000
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 3,303,640 | $22.2M | 11.62% | +0.0% | 2026-08-12 |
| ARK Investment Management LLC | 2,901,635 | $19.5M | 10.21% | +4.8% | 2026-08-14 |
| BlackRock, Inc. | 2,614,012 | $17.6M | 9.20% | +0.0% | 2026-08-07 |
| Sumitomo Mitsui Trust Group, Inc. | 1,963,123 | $13.2M | 6.91% | -14.2% | 2026-07-30 |
| Amova Asset Management Americas, Inc. | 1,960,458 | $13.1M | 6.90% | -14.4% | 2026-08-13 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,114,956 | $7.5M | 3.92% | +0.7% | 2026-06-30 |
| TWO SIGMA INVESTMENTS, LP | 1,091,137 | $7.3M | 3.84% | +0.9% | 2026-08-07 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 951,575 | $6.4M | 3.35% | -2.7% | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 693,660 | $4.7M | 2.44% | +5.0% | 2026-08-12 |
| AQR CAPITAL MANAGEMENT LLC | 675,013 | $4.5M | 2.37% | +318.5% | 2026-08-14 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 647,511 | $4.4M | 2.28% | +225.8% | 2026-08-12 |
| State Street Corp | 569,598 | $3.8M | 2.00% | +4.7% | 2026-08-07 |
| UBS Group AG | 490,632 | $3.3M | 1.73% | +7.1% | 2026-08-13 |
| D. E. Shaw & Co., Inc. | 392,358 | $2.6M | 1.38% | +55.7% | 2026-08-14 |
| Empire Life Investments Inc. | 366,217 | $2.5M | 1.29% | -4.5% | 2026-07-24 |
| Hennion & Walsh Asset Management, Inc. | 346,207 | $2.3M | 1.22% | +23.8% | 2026-07-07 |
| MILLENNIUM MANAGEMENT LLC | 336,996 | $2.3M | 1.19% | -29.6% | 2026-08-14 |
| Goldman Sachs Group Inc | 309,863 | $2.1M | 1.09% | +56.0% | 2026-08-14 |
| BNP PARIBAS FINANCIAL MARKETS | 261,789 | $1.8M | 0.92% | +34.3% | 2026-08-10 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 231,628 | $1.6M | 0.81% | +7.0% | 2026-08-14 |
| Sixth Street Partners Management Company, L.P. | 231,628 | $1.6M | 0.81% | +0.0% | 2026-08-13 |
| Point72 Asset Management, L.P. | 231,582 | $1.6M | 0.81% | +262.7% | 2026-08-14 |
| DIMENSIONAL FUND ADVISORS LP | 221,322 | $1.5M | 0.78% | -23.2% | 2026-08-11 |
| HEARTLAND ADVISORS INC | 219,300 | $1.5M | 0.77% | -14.3% | 2026-08-11 |
| Northern Trust Corp | 204,578 | $1.4M | 0.72% | -6.8% | 2026-08-12 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2024-10-15 to 2025-08-15
Recent transactions
- Most recent: SASSINE ANDY (Chief Financial Officer) — Open market purchase of 1,238 shares on 2025-08-15.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| SASSINE ANDY | Chief Financial Officer | Open market purchase | 2025-08-15 | 1,238 |
| Chivukula Pad | Chief Scientific Officer & COO | Open market sale | 2024-10-15 | 12,000 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2025-08-15 | SASSINE ANDY | Chief Financial Officer | Open market purchase | 1,238 | $16.56 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 06:30 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-23 | 8-K | 2026-09-23 | View on SEC.gov → |
| 2026-08-25 | 8-K | 2026-08-25 | View on SEC.gov → |
| 2026-08-06 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-06 | 8-K | 2026-08-06 | View on SEC.gov → |
| 2026-07-02 | 8-K | 2026-06-26 | View on SEC.gov → |
| 2026-06-15 | 4 | 2026-06-05 | View on SEC.gov → |
| 2026-06-15 | 4 | 2026-06-05 | View on SEC.gov → |
| 2026-06-15 | 4 | 2026-06-05 | View on SEC.gov → |
| 2026-06-15 | 4 | 2026-06-05 | View on SEC.gov → |
| 2026-06-15 | 4 | 2026-06-05 | View on SEC.gov → |
| 2026-06-15 | 4 | 2026-06-05 | View on SEC.gov → |
| 2026-06-15 | 4 | 2026-06-05 | View on SEC.gov → |
Recent news
Headlines about ARCT (Arcturus Therapeutics Holdings Inc.). Links open the publisher — we don’t host full articles.
-
ARCT Dec 2026 30.000 call (ARCT261218C00030000) Interactive Stock Chart - Yahoo Finance
Yahoo! Finance Canada · 2026-10-20 -
ARCT Nov 2026 14.000 call (ARCT261120C00014000) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-20 -
ARCT Nov 2026 14.000 call (ARCT261120C00014000) stock price, news, quote and history
Yahoo Finance Australia · 2026-10-20 -
ARCT Nov 2026 17.500 call (ARCT261120C00017500) stock price, news, quote and history
Yahoo Finance UK · 2026-10-17 -
ARCT Nov 2026 12.500 call (ARCT261120C00012500) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-17 -
Precision Trading with Arcturus Therapeutics Holdings Inc. (ARCT) Risk Zones
Stock Traders Daily · 2026-10-17 -
ARCT270319C00020000 Interactive Stock Chart | ARCT Mar 2027 20.000 call Stock
Yahoo Finance · 2026-10-16 -
Transcript: Arcturus Therapeutics Q2 2026 Earnings Conference Call
Benzinga · 2026-10-14
No headlines in this category right now — try “All”.